AI/ML Innovations Inc.’s Subsidiary Receives Funding Grant for Its Participation in Europe’s Largest Study for the Prevention of Loss of Autonomy in the Elderly
Highlights:The clinical study, led by the University Hospital of Nice, France involves 30,000 patients.AI/ML Innovations' subsidiary, Tech2Heal, has been chosen to provide the "technological backbone" for the study.Tech2heal has been awarded a funding grant of Euro50,000 in conjunction with this study.TORONTO, ON / ACCESSWIRE / October 4, 2023 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to...
Read more








